Exhibit 107

Calculation of Filing Fee Table

FORM S-8

(Form Type)

Fate Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation Rule	Amount  Registered(1)	Proposed  Maximum  Offering  Price Per  Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee
Fees to be Paid	Equity	Common Stock, par value $0.001 per share	457(c) and 457(h)	7,000,000(2)	$1.27(3)	$8,890,000.00	0.00015310	$1,361.06
	Total Offering Amounts					$8,890,000.00		$1,361.06
	Total Fee Offsets							—
	Net Fee Due							$1,361.06

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the number of shares of common stock, par value $0.001 per share (“Common Stock”), of the Registrant registered hereunder includes an indeterminable number of shares of Common Stock that become issuable by reason of any share dividend, share split or other similar transaction.

(2) Represents 7,000,000 additional shares of Common Stock issuable under the Fate Therapeutics, Inc. Second Amended and Restated 2022 Stock Option and Incentive Plan, as approved by the Board of Directors of the Registrant on March 27, 2025 and approved by the Stockholders of the Registrant at the 2025 Annual Meeting of Stockholders on May 29, 2025.

(3) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act on the basis of the average of the high and low sales prices of the Common Stock as reported on the Nasdaq Global Market on May 30, 2025.